These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30305005)

  • 21. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults.
    Insel PS; Donohue MC; Sperling R; Hansson O; Mattsson-Carlgren N
    Ann Clin Transl Neurol; 2020 May; 7(5):776-785. PubMed ID: 32315118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of T
    Boles Ponto LL; Magnotta VA; Menda Y; Moser DJ; Oleson JJ; Harlynn EL; DeVries SD; Wemmie JA; Schultz SK
    J Neuropsychiatry Clin Neurosci; 2020; 32(4):352-361. PubMed ID: 32283991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients.
    Abulafia C; Fiorentini L; Loewenstein DA; Curiel-Cid R; Sevlever G; Nemeroff CB; Villarreal MF; Vigo DE; Guinjoan SM
    J Psychiatr Res; 2019 May; 112():23-29. PubMed ID: 30836202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
    Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widespread distribution of tauopathy in preclinical Alzheimer's disease.
    Schultz SA; Gordon BA; Mishra S; Su Y; Perrin RJ; Cairns NJ; Morris JC; Ances BM; Benzinger TLS
    Neurobiol Aging; 2018 Dec; 72():177-185. PubMed ID: 30292840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low amyloid-β deposition correlates with high education in cognitively normal older adults: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):919-26. PubMed ID: 25425062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease.
    Sánchez SM; Duarte-Abritta B; Abulafia C; De Pino G; Bocaccio H; Castro MN; Sevlever GE; Fonzo GA; Nemeroff CB; Gustafson DR; Guinjoan SM; Villarreal MF
    J Psychiatr Res; 2020 Mar; 122():79-87. PubMed ID: 31931231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
    Mormino EC; Papp KV; Rentz DM; Donohue MC; Amariglio R; Quiroz YT; Chhatwal J; Marshall GA; Donovan N; Jackson J; Gatchel JR; Hanseeuw BJ; Schultz AP; Aisen PS; Johnson KA; Sperling RA
    Alzheimers Dement; 2017 Sep; 13(9):1004-1012. PubMed ID: 28253478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    Donohue MC; Sperling RA; Petersen R; Sun CK; Weiner MW; Aisen PS;
    JAMA; 2017 Jun; 317(22):2305-2316. PubMed ID: 28609533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    Crocco E; Curiel-Cid RE; Kitaigorodsky M; González-Jiménez CJ; Zheng D; Duara R; Loewenstein DA
    J Alzheimers Dis; 2020; 78(2):789-799. PubMed ID: 33074233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease.
    Quenon L; Dricot L; Woodard JL; Hanseeuw B; Gilis N; Lhommel R; Ivanoiu A
    J Int Neuropsychol Soc; 2016 Nov; 22(10):991-1004. PubMed ID: 27903329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.